Technology News and Research

RSS

ActiveCare, Vista Therapeutics announce strategic relationship to develop Nano Biosensors for seniors

ActiveCare, Inc. and Vista Therapeutics, Inc. announced today a strategic relationship to develop Nano Biosensors for ActiveCare's products and services to be utilized by the elderly. These Biosensors will allow ActiveCare to continuously monitor specific chronic diseases commonly occurring in the elderly and thus preventively predict and avoid acute medical events. "This technology is designed to prolong and improve the quality of life of our senior population," stated James Dalton, President of ActiveCare.

18 Jun 2010

Naviscan announces presentations on PEM technology at Society of Nuclear Medicine Annual Meeting

Naviscan's Positron Emission Mammography (PEM) technology was the focus of several presentations and discussions at the Society of Nuclear Medicine Annual Meeting in Salt Lake City. The focus represents a growing interest and validation of how PEM can play an important role in the fight against breast cancer.

18 Jun 2010

General practitioners exchange knowledge, experience via e-mail list started in 1999

Urban Carlén, Department of Applied Information Technology, has studied how a large group of general practitioners interact via an e-mail list. The list started in 1999 and serves as an online community for exchange of knowledge and experience. The submitted e-mails are distributed to all members of the community.

18 Jun 2010

Children's Hospital Boston receives $2.4M Gates Foundation grant to develop novel neonatal vaccines

Children's Hospital Boston announced today that it has received a $2.4 million grant from the Bill & Melinda Gates Foundation. The grant will support the development of novel vaccines for newborns – research that is spearheaded by Ofer Levy, MD, Ph.D., a principal investigator in the Division of Infectious Diseases at Children's.

18 Jun 2010

Precision announces USPTO's issuance of Actions Closing Prosecution in reexamination proceedings for '545, '605 patents

Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has now issued Actions Closing Prosecution in the reexamination proceedings for both U.S. Pat. No. 6,610,545 ("the '545 patent") and U.S. Pat. No. 7,309,605 ("the '605 patent") that are owned by the Institut Pasteur and the Universite Pierre et Marie Curie (UPMC), and licensed to Cellectis, SA (ALCLS).

18 Jun 2010

9th INT'L BIO FORUM & BIO EXPO JAPAN from June 30 - July 2, 2010

9th INT'L BIO FORUM & BIO EXPO JAPAN, organized by Reed Exhibitions Japan, will come back again as Asia's largest bio-event from June 30 - July 2, 2010. "Gene diagnosis" is one of the featured topics for this year.

18 Jun 2010

Gladstone Institute researcher to receive Kyoto Prize in Advanced Technology

The non-profit Inamori Foundation (President: Dr. Kazuo Inamori) today announced that Dr. Shinya Yamanaka will receive its 26th annual Kyoto Prize in Advanced Technology, which for 2010 focuses on the fields of Biotechnology and Medical Technology. Dr. Yamanaka, 47, will receive the award for his pioneering work in developing a technology to generate pluripotent stem cells that does not require the use of human embryos.

18 Jun 2010

Curis reports net income of $4.8M for first-quarter 2010: MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Curis Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

18 Jun 2010

Agilent launches 1260 Infinity bio-inert quaternary liquid chromatography system

Agilent Technologies Inc. today introduced the 1260 Infinity bio-inert quaternary liquid chromatography (LC) system designed to characterize and confirm large biomolecules, especially new biological entities (NBEs) and therapeutic monoclonal antibodies.

18 Jun 2010

Bioniche announces issuance of new patents for MCC, Oligonucleotide technology platforms

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced the issuance of a number of patents for its proprietary Mycobacterial Cell Wall-DNA Complex (MCC) composition and its Oligonucleotide technology platform.

18 Jun 2010

Quick-Med Technologies receives Notice of Allowance for MultiStat family of compounds

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that extends the current patent coverage for the Company's MultiStat family of compounds. The forthcoming patent is part of a portfolio that Quick-Med has licensed from the University of Michigan.

18 Jun 2010

UMHHC expects to achieve 3.3% operating margin on revenues of $2.0 billion in fiscal year 2010

The Hospitals and Health Centers unit of the University of Michigan Health System will finish its fiscal year in strong financial shape, with a positive operating margin nearly twice the size predicted a year ago.

18 Jun 2010

Completion of drug analysis by PBS-Bio enables PharmaGap advance development of novel anti-cancer drug

Predictive Biomarker Sciences Inc. (PBS-Bio) has completed its first drug analysis, enabling Canadian biotech company PharmaGap Inc. to significantly advance a potentially significant anti-cancer medication.

18 Jun 2010

Special public meeting to spotlight stem cell-based therapies for ALS

Local scientists, health advocates and leaders from the California Institute for Regenerative Medicine will gather in San Diego June 23 for a special public meeting to spotlight a new University of California, San Diego grant to pursue novel, fast-tracked stem cell-based therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.

18 Jun 2010

Life Technologies announces product launches in concert with ISSCR 8th Annual Meeting

Life Technologies Corporation, a provider of innovative life science solutions, today announced activities and product launches in concert with the International Society for Stem Cell Research (ISSCR) 8th Annual Meeting that highlight the company's offerings of complete end-to-end solutions for stem cell research. Stem cell research has been shown to be a critical component of regenerative medicine; a basis for identifying drug targets and drug screening; and an important step in the development of therapies to treat a variety of diseases.

18 Jun 2010

Applied BioCode's novel BMB technology to be presented at Biodetection Technologies 2010 Conference

Applied BioCode, Inc. announced today a presentation to be given on their Barcoded Magnetic Beads technology at the Biodetection Technologies 2010 Conference in Arlington, Virginia. The presentation is titled "Multiplexed Assays Go Digital" and will be given by Dr. Winston Ho, President at Applied BioCode, on June 18, 2010.

18 Jun 2010

Richmond Bone & Joint Clinic deploys NCR MediKiosk patient self-service solution

Richmond Bone & Joint Clinic (RBJC), an orthopedic specialty practice, has deployed the leading patient self-service solution from NCR Corporation in three of its four Houston-area locations. The NCR MediKiosk solution automates and speeds routine processes by allowing RBJC patients to check-in for scheduled appointments and remit co-pays and outstanding balances via self-service kiosks.

18 Jun 2010

IMGM acquires 3,100,000 Class B Preferred Shares of Positron

The Shareholders of Imagin Molecular Corporation ("IMGM") have approved, through a consent of over 51% of shareholder vote, certain transactions wherein IMGM completed the acquisition of 3,100,000 Class B Preferred Shares of Positron Corporation which shares are convertible on a 1 for 100 basis into Positron common shares.

18 Jun 2010

NMT Medical receives preliminary results for CLOSURE I PFO/stroke and transient ischemic attack trial

NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced that it has received preliminary results for CLOSURE I, its patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) trial in the U.S.

18 Jun 2010

Transdel, JMSR enter into licensing agreement

Transdel Pharmaceuticals, Inc. and Jan Marini Skin Research, Inc. have entered into a licensing agreement providing JMSR with the exclusive U.S. rights to Transdel's transdermal delivery technology for use in an anti-cellulite cosmeceutical product for the dermatological market.

18 Jun 2010

Technology News and Research

ActiveCare, Vista Therapeutics announce strategic relationship to develop Nano Biosensors for seniors

Naviscan announces presentations on PEM technology at Society of Nuclear Medicine Annual Meeting

General practitioners exchange knowledge, experience via e-mail list started in 1999

Children's Hospital Boston receives $2.4M Gates Foundation grant to develop novel neonatal vaccines

Precision announces USPTO's issuance of Actions Closing Prosecution in reexamination proceedings for '545, '605 patents

9th INT'L BIO FORUM & BIO EXPO JAPAN from June 30 - July 2, 2010

Gladstone Institute researcher to receive Kyoto Prize in Advanced Technology

Curis reports net income of $4.8M for first-quarter 2010: MicroStockProfit.com

Agilent launches 1260 Infinity bio-inert quaternary liquid chromatography system

Bioniche announces issuance of new patents for MCC, Oligonucleotide technology platforms

Quick-Med Technologies receives Notice of Allowance for MultiStat family of compounds

UMHHC expects to achieve 3.3% operating margin on revenues of $2.0 billion in fiscal year 2010

Completion of drug analysis by PBS-Bio enables PharmaGap advance development of novel anti-cancer drug

Special public meeting to spotlight stem cell-based therapies for ALS

Life Technologies announces product launches in concert with ISSCR 8th Annual Meeting

Applied BioCode's novel BMB technology to be presented at Biodetection Technologies 2010 Conference

Richmond Bone & Joint Clinic deploys NCR MediKiosk patient self-service solution

IMGM acquires 3,100,000 Class B Preferred Shares of Positron

NMT Medical receives preliminary results for CLOSURE I PFO/stroke and transient ischemic attack trial

Transdel, JMSR enter into licensing agreement

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News